Dr. Khady Guiro brings a diverse background in Biomedical Engineering and regenerative medicine to her position as lead scientist for Rejenevie, a groundbreaking therapy to restore the aging immune system. After five years of development and pre-clinical research, Dr. Guiro delivered the first in-man therapeutic on Dec. 15, 2017. She finished treatment in February of 2019 of the first five patients, all of whom are being regularly monitored.
As a Postdoctoral Research Fellow with Rutgers New Jersey Medical School, Dr. Guiro studied Tissue Engineering, Biomaterials, Biomechanics, Regenerative Medicine, Molecular Biology, Modeling of the Bone Marrow and Tumor Microenvironment and Hematopoiesis.
While completing her Ph.D. in Biomedical Engineering at Rutgers Graduate School of Biomedical Sciences and New Jersey’s School of Biomedical Sciences, Dr. Guiro worked as research scientist at NASA Langley Aerospace Research Center in the Advanced Materials Branch. There she investigated the effects of a Rotating Cell Culture System on Mesenchymal Stem Cells seeded on tissue-engineered constructs. Dr. Guiro applies her considerable scientific translational and team building skills with a focus on advancing new regenerative therapies, optimizing cell viability and yields, and advancing safety protocols at both the new Okyanos Innovation Center in the US, and the Okyanos Center for Regenerative Medicine in Freeport.